Alkaloids in the human food chain - natural occurrence and possible adverse effects

Molecular Nutrition and Food Research

Volumn 56, Issue 1, 2012, Pages 30-52

  Koleva, Irina I ^a,b   van Beek, Teris A ^a   Soffers, Ans E M F ^a   Dusemund, Birgit ^c   Rietjens, Ivonne M C M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF FOOD TECHNOLOGIES   (Bulgaria)

^c FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

Adverse effects; Alkaloids; Food chain; Natural occurrence; Risk assessment

Indexed keywords

ALKALOID; CARBOLINE DERIVATIVE; ERGOT ALKALOID; NEUROTOXIN; ORNITHINE; PIPERIDINE; PIPERIDINE DERIVATIVE; PYRROLIZIDINE ALKALOID; QUINOLIZIDINE DERIVATIVE; TROPANE DERIVATIVE;

CHEMISTRY; DIET; FOOD; FOOD CHAIN; HUMAN; REVIEW; RISK ASSESSMENT;

ALKALOIDS; CARBOLINES; DIET; ERGOT ALKALOIDS; FOOD; FOOD CHAIN; HUMANS; NEUROTOXINS; ORNITHINE; PIPERIDINES; PYRROLIZIDINE ALKALOIDS; QUINOLIZIDINES; RISK ASSESSMENT; TROPANES;

EID: 84855409340     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100165     Document Type: Review

References (200)

1. Pelletier, S. W., in: Pelletier, S. W. (Ed.), Alkaloids: Chemical and Biological Perspectives, Vol. 1, Wiley, New York 1983.
2. Dewick, P. M., Medicinal Natural Products. A Biosynthetic Approach, John Wiley & Sons, Chichester 2002.
3. Cordell, G. A., Introduction to Alkaloids - A Biogenetic Approach, Wiley, New York 1981.
4. WHO, International Program on Chemical Safety, Pyrrolizidine alkaloids. Environmental Health Criteria 80, 1988.
5. WHO, Discussion paper on pyrrolizidine alkaloids. Joint FAO/WHO food standards programme, Codex committee on contaminants in foods 5th session, The Hague, the Netherlands, 21-25 March 2011, Codex Alimentarius Commission E.
6. ANZFA, Australia New Zealand Food Authority, Pyrrolizidine Alkaloids in Food. A Toxicological Review and Risk Assessment. Technical report series no. 2. 2001.
7. Dharmananda, S., Safety issues affecting herbs: pyrrolizidine alkaloids. 2004, pp. 1-12.
8. Mattocks, A. R., Toxic pyrrolizidine alkaloids in comfrey. Lancet 1980, 2, 1136-1137.
9. BfR, Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung) 2007. Salad mix contaminated with groundsel containing pyrrolizidine alkaloids - BfR Opinion No 028/2007, 10 January 2007, Berlin.
10. Dusemund, B., Appel, K.-E., Lampen, A., in: Risk Assessment of Phytochemicals in Food, DFG Senate commission on Food safety (SKLM), (Eds.), Wiley-VCH Verlag, Weinheim 2010, pp. 1382-1390.
11. Wiedenfeld, H., Plants containing pyrrolizidine alkaloids: toxicity and problems, Food Addit. Contam. Part A 2011, 28, 282-292.
12. Deinzer, M. L., Thomson, P. A., Burgett, D. M., Isaacson, D. L., Pyrrolizidine alkaloids: their occurrence in honey from tansy ragwort (Senecio jacobaea L.). Science 1977, 195, 497-499.
13. Culvenor, C. C., Edgar, J. A., Smith, L. W., Pyrrolizidine alkaloids in honey from Echium plantagineum L. J. Agric. Food. Chem. 1981, 29, 958-960.
14. Kempf, M., Beuerle, T., Buehringer, M., Denner, M. et al., Pyrrolizidine alkaloids in honey: risk analysis by gas chromatography-mass spectrometry. Mol. Nutr. Food Res. 2008, 52, 1193-1200.
15. Kempf, M., Wittig, M., Reinhard, A., von der Ohe, K. et al., Pyrrolizidine alkaloids in honey: comparison of analytical methods. Food Addit. Contam. Part A 2010, 28, 332-347.
16. Prakash, A. S., Pereira, T. N., Reilly, P. E., Seawright, A. A., Pyrrolizidine alkaloids in human diet. Mutat. Res. 1999, 443, 53-67.
17. Wiedenfeld, H., Roeder, E., Bourauel, T., Edgar, J., Pyrrolizidine Alkaloids, Structure and Toxicity, V&R Unipress, Bonn 2008.
18. Chen, T., Mei, N., Fu, P.P., Genotoxicity of pyrrolizidine alkaloids. J. Appl. Toxicol. 2010 30, 183-196.
19. Rietjens, I. M. C. M., Martena, M. J., Boersma, M. G., Spiegelenberg, W., Alink, G. M., Molecular mechanisms of toxicity of important food-borne phytotoxins. Mol. Nutr. Food Res. 2005, 49, 131-158.
20. WHO, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. 1983, Vol. 31.
21. WHO, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 1987, Vol. 1-42, Suppl. 7.
22. WHO, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2002, Vol. 82.
23. Bundesgesundheitsamt, Pyrrolizidin-Alkaloide, Stufe II Abwehr von Arzneimittelrisiken. Bekanntmachung über die Zulassung und Registrierung von Arzneimitteln vom 5. Juni 1992. Bundesanzeiger 1992, 111, 4805.
24. BfR, Bundesinstitut für Risikobewertung. Nulltoleranzen in Lebens- und Futtermitteln. Positionspaper des BfR vom 12. März 2007, Berlin, 2007.
25. COT, Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment, COT Statement on Pyrrolizidine Alkaloids in Food, Food Standard Agency, UK, 2008.
26. National institute of Health, Bioassay of lasiocarpine for possible carcinogenicity. DHEW Publication No. (NIH) 78-839. Technical Report Series 1978, 39, 1-66.
27. NTP, Toxicology and carcinogenesis studies of riddelliine. NTP Technical Report 508, 2003.
28. RIVM, Advisory report on pyrrolizidine alkaloids in herb preparations, 2005.
29. EFSA, European Food Safety Authority, opinion of the scientific panel on contaminants in the food chain on a request from the European Commission related to pyrrolizidine alkaloids as undesirable substances in animal feed. EFSA J. 2007, 447, 1-51.
30. Edgar, J. A., Roeder, E., Molyneux, R. J., Honey from plants containing pyrrolizidine alkaloids: a potential threat to health. J. Agric. Food Chem. 2002, 50, 2719-2730.
31. Van Engelen, J. G. M., Van Egmond, H. P., Speijers, G. J. A. Pyrrolizidine Alkaloiden (Pyrrolizidine Alkaloids); Centrum voor Stoffen en Risicobeoordeling (Centre for Substances and Risk Assessment), CSR rapport 05666A00. Rijksinstituut voor Volksgezondheid en Milieu (National Institute of Public Health and the Environment): The Netherlands, 1997.
32. EFSA, European Food Safety Authority, Tropane alkaloids (from Datura sp.) as undesirable substances in animal feed. Scientific Opinion of the Panel on Contaminants in the Food Chain. (EFSA-Q-2003-063) Adopted on 9 April 2008. EFSA J. 2008, 691, 1-55.
33. Hager, R. O. M., Stramonii Semen, Springer Verlag, Heidelberg 2006.
34. Bucher, E., Meszaros, L., Stechapfelsamen (Datura sp.) und deren Alkaloide in Futtermitteln. Kraftfutter 1989, 3/89, 76-82.
35. Cooper, M. R., Johnson, A. W., Poisonous plants in Britain and their effects on animals and man. Her Majesty's Stationery Office, London, England 1984, 305 pp.
36. Kovatsis, A., Kotsaki-Kovatasi, V. P., Nikolaidis, E., Flaskos, J. et al., The influence of Datura ferox alkaloids on egg-laying henns. Vet. Human. Toxicol. 1994, 93, 89-92.
37. Adamse, P., Van Egmond, H. P., Tropane alkaloids in food. 2010. RIKILT Institute of Food Safety. Repost no. 2010.011. pp 1-24.
38. Perharic, L., Mass tropane alkaloid poisoning due to buckwheat flour contamination. Clin. Toxicol. 2005, 43, 413.
39. Pulewka, P., Die Aufklärung einer ungewöhnlichen durch Datura stramonium in Brotmehl hervorgerufenen Massenvergiftung, Klinische Wochenschrift 1949, Vol. 27, No. 39/40, 672-674.
40. Aga, A., Geyid, A., An outbreak of acute toxicity caused by eating food contaminated with Datura stramonium. Ethiop. J. Health Dev. 1992, 6, 25-31.
41. Onen, C. L., Othol, D., Mbwana, S. K., Manuel, I. L., Datura stramonium mass poisoning in Botswana. S. Afr. Med. J. 2002, 92, 213-214.
42. BfR (Bundesinstitut für Risikobewertung, Federal Institute for Risk Assessment), 2009 Health Assessment No. 020/2009, 27 May 2009, 2009.
43. Brown, J. H., Taylor, P., in: Brunton, L.L., Lazo, J. S., Parker, K. L. (Eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th Edn., McGraw-Hill Med. Publ. Div., New York 2006 pp. 183-200.
44. Kommentar zum Europäischen Arzneibuch, (European Pharmacopoeia Commentary) Wissenschaftliche Verlagsgesellschaft, Stuttgart, 2009.
45. Martindale, 2010. The complete drug reference; Cocaine; Hyoscyamine; Hyoscine; online, Pharmaceutical Press, London, Date of monographs' revision: 26 February 2011.
46. Kommentar zum Europäischen Arzneibuch, (European Pharmacopoeia Commentary) Wissenschaftliche Verlagsgesellschaft, Stuttgart, 2006.
47. Shervette, R. E., III, Schydlower, M., Fearnow, R. G., Lampe, R. M., Jimson 'Loco' Weed Abuse in Adolescents. Pediatrics 1979, 63, 520-523.
48. Dewitt, M. S., Swain, R., Gibson, L. B., Jr., The dangers of jimson weed and its abuse by teenagers in the Kanawha Valley of West Virginia. W V Med J. 1997, 93, 182-185.
49. Szallasi, A., Piperine: researchers discover new flavor in an ancient spice. Trends Pharmacol. Sci. 2005, 26, 437-439.
50. th Edn., Stockton, 2007, pp. 160-162.
51. Pradeep, K. U., Geervani, P., Eggum, B. O., Common Indian spices: Nutrient composition, consumption and contribution to dietary value. Plant Foods Human Nutr. 1993, 44, 137-148.
52. Myers, B. M., Smith, J. L., Graham, D. Y., Effect of red pepper and black pepper on the stomach. Am. J. Gastroenterol. 1987, 82, 211-214.
53. Sheahan, K., Page, D. V., Kemper, T., Suarez, R., Childhood sudden death secondary to accidental aspiration of black pepper. Am. J. Forensic Med. Pathol. 1988, 9, 51-53.
54. Cohle, S. D., Trestrail, J. D., Graham, M. A., Oxley, D. W. et al., Fatal pepper aspiration. Am. J. Dis. Child 1988, 142, 633-636.
55. Johnson, W., Final report on the safety assessment of Capsicum annuum extract, Capsicum annuum fruit extract, Capsicum annuum resin, Capsicum annuum fruit powder, Capsicum frutescens fruit, capsicum frutescens fruit extract, Capsicum frutescens resin, and capsaicin. Int. J. Toxicol. 2007, 26, 3-106.
56. Bhardwaj, R. K., Glaeser, H., Becquemont, L., Klotz, U. et al., Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J. Pharmacol. Exp. Ther. 2002, 302, 645-650.
57. Atal, C. K., Dubey, R. K., Singh, J., Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J. Pharmacol. Exp. Ther. 1985, 232, 258-262.
58. Reen, R. K., Jamwal, D. S., Taneja, S. C., Koul, J. L. et al., Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine. Biochem. Pharmacol. 1993, 46, 229-238.
59. ANZFA, Australia New Zealand Food Authority. Lupin alkaloids in food, a toxicological review and risk assessment. Technical report series no. 3. 2001, pp. 1-21.
60. Reinhard, H., Rupp, H., Sager, F., Streule, M., Zoller, O., Quinolizidine alkaloids and phomopsins in lupin seeds and lupin containing food. J. Chromatogr. A 2006, 1112, 353-360.
61. Butler, W. H., Ford, G. P., Creasy, D. M., A 90-day feeding study of lupin (Lupinus angustifolius) flour spiked with lupin alkaloids in the rat. Food Chem. Toxicol. 1996, 34, 531-536.
62. Di Grande, A., Paradiso, R., Amico, S., Fulco, G. et al., Anticholinergic toxicity associated with lupin seed ingestion: case report. Eur. J. Emerg. Med. 2004, 11, 119-120.
63. Litkey, J., Dailey, M. W., Anticholinergic toxicity associated with the ingestion of lupini beans. Am. J. Emerg. Med. 2007, 25, 215-217.
64. Marquez, R. L., Gutierrezrave, M., Miranda, F. I., Acute-poisoning by lupine seed debittering water. Vet. Human Toxicol. 1991, 33, 265-267.
65. Petterson, D. S., Greirson, B. N., Allen, D. G., Harris, D. J. et al., Disposition of lupanine and 13-hydroxylupanine in man. Xenobiotica 1994, 24, 933-941.
66. Ballester, D., Yanez, E., Garcia, R., Erazo, S. et al., Chemical composition, nutritive value, and toxicological evaluation of two species of sweet Lupine (Lupinus albus and Lupinus luteus). J. Agric. Food Chem. 1980, 28, 402-405.
67. Ballester, D. R., Brunser, O., Saitua, M. T., Egana, J. I. et al., Safety evaluation of sweet lupine (Lupinus albus cv. Multolupa). II. Nine-month feeding and multigeneration study in rats. Food Chem. Toxicol. 1984, 22, 45-48.
68. Hager, R. O. M., Papaver Semen, Springer Verlag, Heidelberg 2006.
69. Kommentar zum Europäischen Arzneibuch, (European Pharmacopoeia Commentary) Wissenschaftliche Verlagsgesellschaft, Stuttgart, 2004.
70. Rochholz, G., Westphal, F., Wiesbrock, U. O., Schütz, H. W., Opiat-Nachweis in Urin, Blut und Haaren nach Verzehr mohnsamenhaltiger Backwaren. Blutalkohol 2004, 41, 319-329.
71. Appendino, G., Tagliatela-Scafati, O., in: Maffei, M. (Ed.), Drug-like Compounds from Food Plants and Spices, Taylor & Francis, London 2003.
72. BfR, (Bundesinstitut für Risikobewertung, Federal Institute for Risk Assessment), BfR recommends provisional daily upper intake level and a guidance value for morphine in poppy seeds. BfR Health Assessment 2006, No. 12/2006.
73. Meadway, C., George, S., Braithwaite, R., Opiate concentrations following the ingestion of poppy seed products-evidence for 'the poppy seed defence'. Forensic Sci. Int. 1998, 96, 29-38.
74. General, J., Unbehend, G., Lindhauer, M. G., Kniel, B., Moser, M., Untersuchungen zur reduzierung von morphin in mohnsamen und mohngebäck mit praktikablen technologischen maßnahmen. Getreidetechnologie 2007, 61, 36-42.
75. Forth, W., Henschler, D., Rummel, W., Allgemeine und Spezielle Pharmakologie und Toxikologie, Elsevier, München 2009.
76. Goodman & Gilman's, The Pharmacological Basis of Therapeutics, 11th Edn., McGraw-Hill, New York 2006.
77. Frohne, D., Pfänder, H. J., Giftpflanzen; 5. Auflage, Wissenschaftliche Verlagsgesellschaft, Stuttgart 2004.
78. Hänsel, R., Sticher, O., Pharmakognosie - Phytopharmazie; 8. Auflage, Springer, Heidelberg 2007.
79. Zagon, I. S., McLaughlin, P. J., Morphine and brain growth retardation in the rat. Pharmacology 1977, 15, 276-282.
80. Zagon, I. S., McLaughlin, P. J., Effects of chronic morphine administration on pregnant rats and their offspring. Pharmacology 1977, 15, 302-310.
81. Fujinaga, M., Mazze, R. I., Teratogenic and postnatal developmental studies of morphine in Sprague-Dawley rats. Teratology 1988, 38, 401-410.
82. ® Service, Frankfurt/Main 2007.
83. Wirth, W., Gloxhuber, C., Toxikologie - für Ärzte, Naturwissenschaftler und Apotheker, Georg Thieme Verlag, Stuttgart 1981.
84. Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. Official Journal of the European Communities L 31/1, 1.2.2002, 2002.
85. BfR, (Bundesinstitut für Risikobewertung, Federal Institute for Risk Assessment). Cases of Poisoning Reported by Physicians. BfR Press and Public Relations Office 2005.
86. Allen, J. R. F., Holmstedt, B. R., The simple beta-carboline alkaloids. Phytochemistry 1980, 19, 1573-1582.
87. Cao, R., Peng, W., Wang, Z., Xu, A., Beta-carboline alkaloids: biochemical and pharmacological functions. Curr. Med. Chem. 2007, 14, 479-500.
88. Sato, H., Abe, T., Kikuchi, T., Endo, T. et al., Changes in the production of reactive oxygen species from neutrophils following a 100-km marathon. Nippon Eiseigaku Zasshi 1996, 51, 612-616.
89. Herraiz, T., Ough, C. S., Chemical and technological factors determining tetrahydro-beta-carboline-3-carboxylic acid content in fermented alcoholic beverages. J. Agric. Food Chem. 1993, 41, 959-964.
90. Pfau, W., Skog, K., Exposure to beta-carbolines norharman and harman. J. Chromatogr. B 2004, 802, 115-126.
91. Brockstedt, U., Pfau, W., Formation of 2-amino-alpha-carbolines in pan-fried poultry and P-32-postlabeling analysis of DNA adducts. Z. Lebensm.-Unters. Forsch. 1998, 207, 472-476.
92. Robbana-Barnat, S., Rabache, M., Rialland, E., Fradin, J., Heterocyclic amines: occurrence and prevention in cooked food. Environ. Health Perspect. 1996, 104, 280-288.
93. Herraiz, T., Relative exposure to beta-carbolines norharman and harman from foods and tobacco smoke. Food Addit. Contam. 2004, 21, 1041-1050.
94. Herraiz, T., Identification and occurrence of the bioactive beta-carbolines norharman and harman in coffee brews. Food Addit. Contam. 2002, 19, 748-754.
95. Louis, E. D., Zheng, W., Applegate, L., Shi, L., Factor-Litvak, P., Blood harmane concentrations and dietary protein consumption in essential tremor. Neurology 2005, 65, 391-396.
96. Airaksinen, M. M., Kari, I., Beta-carbolines, psychoactive compounds in the mammalian body. Part I: occurrence, origin and metabolism. Med. Biol. 1981, 59, 21-34.
97. Airaksinen, M. M., Kari, I., Beta-carbolines, psychoactive compounds in the mammalian body. Part II: effects. Med. Biol. 1981, 59, 190-211.
98. Boeira, J. M., da Silva, J. M., Erdtmann, B., Henriques, J.A., Genotoxic effects of the alkaloids harman and harmine assessed by comet assay and chromosome aberration test in mammalian cells in vitro. Pharmacol. Toxicol. 2001, 89, 287-294.
99. Bringmann, G., Bruckner, R., Mossner, R., Feineis, D. et al., Effect of 1-trichloromethyl-1, 2, 3, 4-tetrahydro-beta-carboline (TaClo) on human serotonergic cells. Neurochem. Res. 2000, 25, 837-843.
100. Collins, M. A., Alkaloids, alcohol and Parkinson's disease. Parkinsonism Relat. Disord. 2002, 8, 417-422.
101. Kuhn, W., Muller, T., Grosse, H., Rommelspacher, H., Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients. J. Neural. Transm. 1996, 103, 1435-1440.
102. Hager, R. O. M., Cinchona, Springer Verlag, Heidelberg 2006.
103. ® Service, Frankfurt/Main 2007.
104. Aromenverordnung vom 22.12.1981 in der Neufassung vom 2.5. 2006, 2006.
105. Ballestero, J. A., Plazas, P. V., Kracun, S., Gomez-Casati, M. E. et al., Effects of quinine, quinidine, and chloroquine on 910 nicotinic cholinergic receptors. Mol. Pharmacol. 2005, 68, 822-829.
106. Worden, A. N., Frape, D. L., Shephard, N. W., Consumption of quinine hydrochloride in tonic water. Lancet 1987, 1, 271-272.
107. Brinton, G. S., Norton, E. W., Zahn, J. R., Knighton, R. W., Ocular quinine toxicity. Am. J. Ophthalmol. 1980, 90, 403-410.
108. White, N. J., Warrell, D. A., Chanthavanich, P., Looareesuwan, S. et al., Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N. Engl. J. Med. 1983, 309, 61-66.
109. Boland, M. E., Roper, S. M., Henry, J. A., Complications of quinine poisoning. Lancet 1985, 325, 384-385.
110. Dyson, E. H., Proudfoot, A. T., Prescott, L. F., Heyworth, R., Death and blindness due to overdose of quinine. Br. Med. J. 1985, 291, 31-33.
111. Evans, A. N., Brooke, O. G., West, R. J., The ingestion by pregnant women of substances toxic to the foetus. Practitioner 1980, 224, 315-319.
112. Baylon, H., Sur les incidents et accidents imputables à la quinine. Med. Nut. 1979, 15, 437-441.
113. Murray, J. A., Abbott, I., Anderson, D. A., Morgan, A. D., Bitter lemon purpura. Br. Med. J. 1979, 2, 1551-1552.
114. Barr, E., Douglas, J. F., Hill, C. M., Recurrent acute hypersensitivity to quinine. Br. Med. J. 1990, 301, 323.
115. Aster, R. H., Quinine sensitivity: a new cause of the hemolytic uremic syndrome. Ann. Intern. Med. 1993, 119, 243-244.
116. Clark, D. J., Clinical curio: warfarin and tonic water. Br. Med. J. 1983, 286, 1258.
117. st Report, Evaluation of certain food additives and contaminants, WHO Technical Report Series, World Health Organization, Geneva 1993, 1-53.
118. BfR, (Bundesinstitut für Risikobewertung, Federal Institute for Risk Assessment), 2008 Quinine-containing beverages may cause health problems. Updated BfR Health Assessment* No 020/2008, 17 February 2005, Updated 9 May 2008.
119. EFSA, European Food Safety Authority, Three quinine salts from the Priority list from chemical group 30, Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (EFSA-Q-2003-172B). Adopted on 22 May 2008. EFSA J. 2008, 739, 1-18.
120. Schardl, C. L., Panaccione, D. G., Tudzynski, P., The Alkaloids: Chemistry and Biology, Elsevier, Amsterdam 2006, pp. 45-86.
121. BfR (Bundesinstitut für Risikobewertung, Federal Institute for Risk Assessment). Mutterkornalkaloide im Roggenmehl. Stellungnahme des BfR vom 22.01.2004, 2004.
122. Dusemund, B., Altmann, H. J., Lampen, A., II, Toxikologische Bewertung Mutterkornalkaloid-kontaminierter Roggenmehl. J. Consumer Prot. Food Safety 2006, 1, 150-152.
123. EFSA, European Food Safety Authority, Opinion of the Scientific Panel on contaminants in the food chain on a request from the commission related to ergot as undesirable substance in animal feed. Question No. EFSA-Q-2003-38. EFSA J. 2005, 225, 1-27.
124. Horvath, J., Fross, R. D., Kleiner-Fisman, G., Lerch, R. et al., Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. Movement Disorders 2004, 19, 656-662.
125. Panaccione, D. G., Coyle, C. M., Abundant respirable ergot alkaloids from the common airborne fungus Aspergillus fumigatus. Appl. Environ. Microbiol. 2005, 71, 3106-3111.
126. Šmejkal-Jagar, L., Boranić, M., Serotonin, serotoninergic agents and their antagonists suppress humoral immune reaction in vitro. Res. Exp. Med. 1994, 194, 297-304.
127. Janssen, G. B., Beems, R. B., Elvers, L. H., Speijers, G. J. A., Subacute toxicity of α-ergocryptine in Sprague-Dawley rats. 2: metabolic and hormonal changes. Food Chem. Toxicol. 2000, 38, 689-695.
128. Janssen, G. B., Beems, R. B., Speijers, G. J. A., Van Egmond, H. P., Subacute toxicity of α-ergocryptine in Sprague-Dawley rats. 1: general toxicological effects. Food Chem. Toxicol. 2000, 38, 679-688.
129. Peters-Volleberg, G. W. M., Beems, R. B., Speijers, G. J. A., Subacute toxicity of ergometrine maleate in rats. Food Chem. Toxicol. 1996, 34, 951-958.
130. Meijer, G. W., Janssen, G. B., Beynen, A. C., Speijers, G. J. A., Is dietary ergotamine atherogenic in the rabbit? Food Chem. Toxicol. 1992, 30, 731-734.
131. Schneider, D. J., Miles, C. O., Garthwaite, I., Van Halderen, A. et al., First report of field outbreaks of ergot-alkaloid toxicity in South Africa. J. Vet. Res. 1996, 63, 97-108.
132. Mühlberger, V., Abbrederis, K., Knapp, E., Myokardinfarkt unter Ergotamine Medikation bei einem Jugendlichen mit normalen Koronararterien. Deutsche Medizinische Wochenschrift 1983, 108, 623-626.
133. Martindale, The complete drug reference, Ergotamine Tartrate, Ergometrine Maleate; online, Pharmaceutical Press, London, Date of monographs revision: 27 November 2010.
134. Matthews, W., Progress on EU mycotoxin legislation. 2004.
135. Hokkanen, E., Waltimo, O., Kallanranta, T., Toxic effects of ergotamine used for migraine. Headache 1978, 18, 95-98.
136. Zavaleta, E. G., Fernandez, B. B., Grove, M. K., Kaye, M. D., Anthony's fire (ergotamine induced leg ischemia) - a case report and review of the literature. Angiology 2001, 52, 349-356.
137. Ács, N., A possible dose-dependent teratogenic effect of ergotamine. Reprod. Toxicol. 2006, 22, 551-552.
138. Bánhidy, F., Acs, N., Puho, E., Czeizel, A. E., Ergotamine treatment during pregnancy and a higher rate of low birthweight and preterm birth. Br. J. Clin. Pharmacol. 2007, 64, 510-516.
139. Raymond, G. V., Teratogen update: ergot and ergotamine. Teratology 1995, 51, 344-347.
140. EU Directive 2002/32/EC of the European parliament and of the council of 7 May 2002 on undesirable substances in animal feed. Official Journal of the European Communities 30.5.2002 L140/10-L140/19.
141. Baumann, U., Hunziker, H. R., Zimmerli, B., Ergot alkaloids in Swiss cereal products. Mitteil. Gebiete Lebensmittelunters. Hyg. 1985, 76, 609-630.
142. Altug, T., Introduction to Toxicology and Food, CRC Press LLC, London 2003.
143. Yildiz, D., Nicotine, its metabolism and an overview of its biological effects. Toxicon 2004, 43, 619-632.
144. Siegmund, B., Leitner, E., Pfannhauser, W., Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake. J. Agric. Food Chem. 1999, 47, 3113-3120.
145. Davis, R. A., Stiles, M. F., deBethizy, J. D., Reynolds, J. H., Dietary nicotine: a source of urinary cotinine. Food Chem. Toxicol. 1991, 29, 821-827.
146. Domino, E. F., Hornbach, E., Demana, T., The nicotine content of common vegetables. N. Engl. J. Med. 1993, 329, 437.
147. Sheen, S. J., Detection of nicotine in foods and plant materials. J. Food Sci. 1988, 53, 1572-1573.
148. Zwickenpflug, W., Meger, M., Richter, E., Occurrence of the tobacco alkaloid myosmine in nuts and nut products of Arachis hypogaea and Corylus avellana. J. Agric. Food Chem. 1998, 46, 2703-2706.
149. Tyroller, S., Zwickenpflug, W., Richter, E., New sources of dietary myosmine uptake from cereals, fruits, vegetables, and milk. J. Agric. Food Chem. 2002, 50, 4909-4915.
150. Schütte-Borkovec, K., Vorkommen und Toxikokinetik von Myosmin in Abhängigkeit von Rauchen und Ernährung. Institut für Hygiene und Technologie der Lebensmittel tierischen Ursprungs der Tierärztlichen Fakultät und dem Walther Straub Institut für Pharmakologie und Toxikologie der Ludwig-Maximilians-Universität München 2008.
151. Kleinsasser, N. H., Wallner, B. C., Harreus, U. A., Zwickenpflug, W., Richter, E., Genotoxic effects of myosmine in human lymphocytes and upper aerodigestive tract epithelial cells. Toxicology 2003, 192, 171-177.
152. Wilp, J., Zwickenpflug, W., Richter, E., Nitrosation of dietary myosmine as risk factor of human cancer. Food Chem. Toxicol. 2002, 40, 1223-1228.
153. Zwickenpflug, W., Tyroller, S., Richter, E., Metabolism of myosmine in Wistar rats. Drug Metab. Dispos. 2005, 33, 1648-1656.
154. Frohne, D., Pfaender, P. H. J., Poisonous Plants, Manson Publishing, London 2005.
155. Slanina, P., Solanine (glycoalkaloids) in potatoes: toxicological evaluation. Food Chem. Toxicol. 1990, 28, 759-761.
156. Friedman, M., Dao, L., Distribution of glycoalkaloids in potato plants and commercial potato products. J. Agric. Food Chem. 1992, 40, 419-423.
157. Bushway, R. J., Ponnampalam, R., α-Chaconine and -solanine content of potato products and their stability during several modes of cooking. J. Agric. Food Chem. 1981, 29, 814-817.
158. van Gelder, W. M. J., Steroidal glycoalkaloids in Solanum species: consequences for potato breeding and food safety, Thesis Landbouwuniversiteit Wageningen, October 11, 1989, pp. 184.
159. Lampitt, L. H., Bushill, J. H., Rooke, H.S., Jackson, E. M., Solanine. Glycoside of the potato. II. Its distribution in the potato plant. J. Soc. Chem. Ind. 1943, 62, 48-51.
160. Friedman, M., Potato glycoalkaloids and metabolites: roles in the plant and in the diet. J. Agric. Food Chem. 2006, 54, 8655-8681.
161. Friedman, M., Henika, P. R., Mackey, B. E., Effect of feeding solanidine, solasodine and tomatidine to non-pregnant and pregnant mice. Food Chem. Toxicol. 2003, 41, 61-71.
162. Groen, K., Pereboom-de Fauw, D. P., Besamusca, P., Beekhof, P. K. et al., Bioavailability and disposition of 3H-solanine in rat and hamster. Xenobiotica 1993, 23, 995-1005.
163. Hellenas, K. E., Nyman, A., Slanina, P., Lööf, L., Gabrielsson, J., Determination of potato glycoalkaloids and their aglycone in blood serum by high-performance liquid chromatography. Application to pharmacokinetic studies in humans. J. Chromatogr. 1992, 573, 69-78.
164. Mensinga, T. T., Sips, A. J. A. M., Rompelberg, C. J. M., van Twillert, K. et al., Potato glycoalkaloids and adverse effects in humans: an ascending dose study. Reg. Toxicol. Pharmacol. 2005, 41, 66-72.
165. Nigg, H. N., Phytochemical Resources for Medicine and Agriculture, Plenum Press, New York 1992.
166. McMillan, M., Thompson, J. C., An outbreak of suspected solanine poisoning in schoolboys: examination of criteria of solanine poisoning. Q. J. Med. 1979, 48, 227-243.
167. Patel, B., Schutte, R., Sporns, P., Doyle, J. et al., Potato glycoalkaloids adversely affect intestinal permeability and aggravate inflammatory bowel disease. Inflamm. Bowel Dis. 2002, 8, 340-346.
168. Korpan, Y. I., Nazarenko, E. A., Skryshevskaya, I. V., Martelet, C. et al., Potato glycoalkaloids: true safety or false sense of security? Trends Biotechnol. 2004, 22, 147-151.
169. de Vries, J., van Stigt Thans, M. J., Food Safety and Toxicity, CRC Press LLC, London 1996.
170. th meeting of the JECFA, WHO Food additives series 30. World Health Organization, Geneva 1993.
171. Renwick, J. H., Hypothesis: anencephaly and spina bifida are usually preventable by avoidance of a specific but unidentified substance present in certain potato tubers. Br. J. Prev. Soc. Med. 1972, 26, 67-88.
172. Nevin, N. C., Merrett, J. D., Potato avoidance during pregnancy in women with a previous infant with either anencephaly and/or spina bifida. Br. J. Prev. Soc. Med. 1975, 29, 111-115.
173. Harvey, M. H., Morris, B. A., McMillan, M., Marks, V., Potato steroidal alkaloids and neural tube defects: serum concentrations fail to demonstrate a causal relation. Hum. Toxicol. 1986, 5, 249-253.
174. Chaube, S., Swinyard, C. A., Teratological and toxicological studies of alkaloidal and phenolic compounds from Solanum tuberosum L. Toxicol. Appl. Pharmacol. 1976, 36, 227-237.
175. Hellenaes, K. E., Cekan, E., Slanina, P., Bergman, K., Studies of embryotoxicity and the incidence of external malformations after continuous intravenous infusion of R-chaconine in pregnant rats. Pharmacol. Toxicol. 1992, 70, 381-383.
176. Smith, D. B., Roddick, J. G., Jones, J. L., Potato glycoalkaloids: some unanswered questions. Trends Food Sci. Technol. 1996, 7, 126-131.
177. Friedman, M., Tomato glycoalkaloids: role in the plant and in the diet. J. Agric. Food Chem. 2002, 50, 5751-5780.
178. Friedman, M., Analysis of biologically active compounds in potatoes (Solanum tuberosum), tomatoes (Lycopersicon esculentum), and jimson weed (Datura stramonium) seeds. J. Chromatogr. A 2004, 1054, 143-155.
179. Friedman, M., Henika, P. R., Mackey, B. E., Feeding of potato, tomato and eggplant alkaloids affects food consumption and body and liver weights in mice. J. Nutr. 1996, 126, 989-999.
180. Knight, C. A., Knight, I., Mitchell, D. C., Zepp, J. E., Beverage caffeine intake in US consumers and subpopulations of interest: estimates from the share of intake panel survey. Food Chem. Toxicol. 2004, 42, 1923-1930.
181. Leitsätze für Erfrischungsgetränke, 18.03.2003, Gemeinsames Ministerialblatt (GMBL) no. 18, p. 383.
182. Aniszewski, T., Alkaloids - Secrets of Life. Alkaloid Chemistry, Biological Significance, Applications and Ecological Role, Elsevier, Amsterdam 2007.
183. Hicks, M. B., Hsieh, Y. H. P., Bell, L. N., Tea preparation and its influence on methylxanthine concentration. Food Res. Int. 1996, 29, 325-330.
184. Scott, N. R., Chakraborty, J., Marks, V., Caffeine consumption in the United Kingdom: a retrospective survey. Food Sci. Nutr. 1989, 42F, 183-119.
185. Stavric, B., Methylxanthines: toxicity to humans. 3. Theobromine, paraxanthine and the combined effects of methylxanthines. Food Chem. Toxicol. 1988, 26, 725-733.
186. Westerterp-Plantenga, M., Diepvens, K., Joosen, A. M., Berube-Parent, S., Tremblay, A., Metabolic effects of spices, teas, and caffeine. Physiol. Behav. 2006, 89, 85-91.
187. Dulloo, A. G., Duret, C., Rohrer, D., Girardier, L. et al., Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am. J. Clin. Nutr. 1999, 70, 1040-1045.
188. Dulloo, A. G., Seydoux, J., Girardier, L., Chantre, P., Vandermander, J., Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int. J. Obes. Relat. Metab. Disord. 2000, 24, 252-258.
189. Kommentar zum Europäischen Arzneibuch. (European Pharmacopoeia Commentary) Wissenschaftliche Verlagsgesellschaft, Stuttgart, 2007.
190. Kotsopoulos, J., Vitonis, A. F., Terry, K. L., De Vivo, I. et al., Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer. Cancer Causes Control 2009, 20, 335-344.
191. Nkondjock, A., Coffee consumption and the risk of cancer: an overview. Cancer Lett. 2009, 277, 121-125.
192. Tworoger, S. S., Gertig, D. M., Gates, M. A., Hecht, J. L., Hankinson, S. E., Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer 2008, 112, 1169-1177.
193. Michels, K. B., Willett, W. C., Fuchs, C. S., Giovannucci, E., Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J. Natl. Cancer Inst. 2005, 97, 282-292.
194. Tavani, A., La Vecchia, C., Coffee, decaffeinated coffee, tea and cancer of the colon and rectum: a review of epidemiological studies, 1990-2003. Cancer Causes Control 2004, 15, 743-757.
195. Rosenberg, L., Palmer, J. R., Kelly, J. P., Kaufman, D. W., Shapiro, S., Coffee drinking and nonfatal myocardial infarction in men under 55 years of age. Am. J. Epidemiol. 1988, 128, 570-578.
196. Higdon, J. V., Frei, B., Coffee and health: a review of recent human research. Crit. Rev. Food Sci. Nutr. 2006, 46, 101-123.
197. Weng, X., Odouli, R., Li, D. K., Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am. J. Obstet. Gynecol. 2008, 198, 279.e1-279.e8.
198. CARE Study Group. Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. Br. Med. J. 2008, 337, a2332.
199. FSA, Food Standard Agency, New caffeine advice for pregnant women, 2008.
200. EFSA. Flavouring Group Evaluation 49, (FGE.49): xanthin alkaloids from the priority list from chemical group 30, scientific opinion of the panel on food additives, flavourings, processing aids and materials in